Amphotericin B Liposome Injection, Powder, Lyophilized, For Suspension
Product Images NDC 67457-926

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amphotericin B Liposome (NDC 67457-926). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Schematic Depiction Of The Liposome (Image 01)

Illustration showing a cross-sectional view of a liposome with labeled components: amphotericin B molecules inside and a phospholipid bilayer forming the liposome membrane.*

FDA Label Image

Chemical Structure Of Amphotericin B (Image 02)

Chemical structure of Amphotericin B liposome active ingredient depicting its molecular arrangement with multiple hydroxyl groups and a characteristic polyene macrolide structure.*

FDA Label Image

Figure 1 Renal Function In Adult Patients (Image 03)

A line graph depicting mean change in creatinine levels (mg/dL) over weeks on study for Amphotericin B liposome injections. Two dosage groups are compared: 3 mg/kg/day and 0.6 mg/kg/day. The graph shows creatinine level changes plotted against weeks, with sample sizes indicated for each point.*

FDA Label Image

Figure 2 Average Serum Creatinine Concentrations (Image 04)

A line graph showing mean creatinine concentration (mg/dL) over days of test for Amphotericin B liposome. Two datasets are plotted: 'Patients Whose Pretreatment Value was Greater Than 1.7 mg/dL' and 'All Episodes,' illustrating creatinine levels declining or stabilizing over a 45-day period.*

FDA Label Image

Amphotericin B Liposome For Injection 50 mg/vial Carton Label (Image 05)

Packaging label for Amphotericin B Liposome for Injection 50 mg/vial, a lyophilized powder for suspension intended for intravenous use. The label shows it is a single-dose vial, prescription only, manufactured by Mylan Institutional LLC. It includes storage instructions, contents, and a warning that it is not interchangeable with other Amphotericin B products. The label displays two barcodes and the product NDC 67457-926-50.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.